江西天新药业股份有限公司2025年第一次临时股东大会决议公告

Meeting Overview - The first extraordinary general meeting of shareholders was held on September 17, 2025, at the company's conference room in Jiangxi Province [2] - The total share capital of the company is 437,780,000 shares, with 435,170,280 shares eligible for voting after excluding repurchased shares [2] Voting and Resolutions - No resolutions were rejected during the meeting [2] - The meeting adopted a combination of on-site and online voting methods, presided over by Chairman Xu Jiangnan, in compliance with relevant laws and regulations [3] - Two key resolutions were passed: 1. The proposal to abolish the supervisory board and amend the Articles of Association [5] 2. The proposal to revise, formulate, and abolish certain corporate governance systems [5] - The first resolution required a two-thirds majority of the voting shares present to pass, which was achieved [6] Legal Verification - The meeting was witnessed by lawyers from Beijing Zhonglun (Shanghai) Law Firm, confirming that the procedures and voting were in accordance with applicable laws and the company's Articles of Association [7] Employee Representative Director Election - On September 17, 2025, the company held its first employee representative meeting, electing Li Quanguo as the employee representative director for the third board of directors [9] - Li Quanguo meets the qualifications for directorship as per relevant laws and regulations, and his term will last until the end of the current board's term [10]